Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2201664rdf:typepubmed:Citationlld:pubmed
pubmed-article:2201664lifeskim:mentionsumls-concept:C0030567lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C0040822lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C0023570lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2201664lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2201664pubmed:issue3lld:pubmed
pubmed-article:2201664pubmed:dateCreated1990-9-25lld:pubmed
pubmed-article:2201664pubmed:abstractTextA single blind placebo-controlled study has been performed in order to investigate objectively the acute tremorolytic effect of oral L-Dopa in ten parkinsonians chronically treated with L-Dopa. Finger tremor was assessed by means of a computerized accelerometer method, at rest and during maintenance of a fixed posture. Both resting and postural tremor were significantly influenced by L-Dopa. An "acute test" with oral L-Dopa, especially when different tremor components are investigated, may be useful for identifying objectively parkinsonians whose tremor does not respond to drug therapy or shows a deterioration of drug-responsiveness.lld:pubmed
pubmed-article:2201664pubmed:languageenglld:pubmed
pubmed-article:2201664pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2201664pubmed:citationSubsetIMlld:pubmed
pubmed-article:2201664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2201664pubmed:statusMEDLINElld:pubmed
pubmed-article:2201664pubmed:monthJunlld:pubmed
pubmed-article:2201664pubmed:issn0392-0461lld:pubmed
pubmed-article:2201664pubmed:authorpubmed-author:MarshallR WRWlld:pubmed
pubmed-article:2201664pubmed:authorpubmed-author:TedeschiGGlld:pubmed
pubmed-article:2201664pubmed:authorpubmed-author:BonavitaVVlld:pubmed
pubmed-article:2201664pubmed:authorpubmed-author:SassoEElld:pubmed
pubmed-article:2201664pubmed:issnTypePrintlld:pubmed
pubmed-article:2201664pubmed:volume11lld:pubmed
pubmed-article:2201664pubmed:ownerNLMlld:pubmed
pubmed-article:2201664pubmed:authorsCompleteYlld:pubmed
pubmed-article:2201664pubmed:pagination259-63lld:pubmed
pubmed-article:2201664pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:meshHeadingpubmed-meshheading:2201664-...lld:pubmed
pubmed-article:2201664pubmed:year1990lld:pubmed
pubmed-article:2201664pubmed:articleTitleTremor in Parkinson disease: acute response to oral levodopa.lld:pubmed
pubmed-article:2201664pubmed:affiliationIstituto di Scienze Neurologiche, I Facoltà di Medicina, Università di Napoli.lld:pubmed
pubmed-article:2201664pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2201664pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2201664pubmed:publicationTypeControlled Clinical Triallld:pubmed